XBiotech Inc (NASDAQ:XBIT)
| 16.30 Delayed Data As of Jan 15 |  -0.59 / -3.49%Today’s Change | 8.72 Today|||52-Week Range 25.25 | +4.15% Year-to-Date |
Latest XBIT News | Press Releases
No recent news for XBiotech Inc.
Today’s Trading
| Previous close | 16.89 |
| Today’s open | 17.01 |
| Day’s range | 16.27 - 17.56 |
| Volume | 2,227 |
| Average volume (3 months) | 100,611 |
| Market cap | $478.7M |
Data as of 4:00pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 1.1 |
| Price/Sales | -- |
| Price/Book | 0.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AUTLAutolus Therapeutics... | +0.08 | +0.90% |
| RCELAVITA Medical Inc | +1.10 | +5.07% |
| APLTApplied Therapeutics... | -0.08 | -0.37% |
| SURFSurface Oncology Inc | +0.32 | +2.68% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Last reporting date | May 13, 2020 |
| EPS forecast (this quarter) | $0.06 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | $668.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
